There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Unfortunately, these cancers tend to occur in highly visible areas of the body such as the face, neck, chest, upper back, arms and legs. Surgery has historically been the mainstay of treatment for these cancers and is an area of expertise for Dr. Hooman Khorasani; however, even the greatest surgeons are not able to produce a scar-free surgery. This prospect of scarring can add considerable angst to an already scary diagnosis of skin cancer.
Laser therapy has revolutionized the treatment of superficial skin cancers in cosmetically sensitive areas. If you have been diagnosed with actinic keratosis (pre-cancer spots), squamous cell carcinoma (SCC) in situ (cancer limited to the top layer of skin), or a superficial basal cell carcinoma (BCC), you may be a candidate for minimally-invasive laser surgery. Our office uses a specialized CO2 laser known as PreciseFX, to vaporize the cancer while preserving the surrounding healthy skin. The PreciseFX technology coupled with Dr. Khorasani’s skin cancer and cosmetic surgery expertise, can provide you with a successful treatment that optimizes your medical needs and aesthetic goals.
Your skin is composed of millions of cells. Sun exposure, age, genetics, stress and other factors can cause some of these cells to mutate and behave abnormally. These mutated cells multiply rapidly and form cancerous tumors in the skin. The specific type of cell involved in this abnormal growth pattern determines if the cancer is a basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma. Skin cancer is the most common malignancy in the United States and will impact one in five adults by the age of seventy. You are not alone in this battle!
Treatment of your skin cancer depends on its type, stage (as determined by your dermatologist and pathologist), location, and your overall health. Melanoma, the most dangerous of skin cancers, must be treated aggressively with surgery, chemotherapy, and/or radiation. The more mild pre-cancers and cancers like actinic keratosis (AK), basal cell carcinomas (BCC), and squamous cell carcinomas (SCC) can be addressed with a broader array of therapies.
Mohs micrographic surgery is best suited for non-superficial basal cell carcinomas and squamous cell carcinomas in cosmetically sensitive areas. As a fellowship-trained Mohs micrographic surgeon, Dr. Khorasani has treated over sixteen thousand skin cancers with medical integrity and advanced technical proficiency. His commitment to optimizing health and aesthetic outcomes has earned him an international reputation of excellence and multiple peer-reviewed research publications.Learn more about Mohs micrographic surgery with Dr. Khorasani.
Actinic keratosis (pre-cancer cells), superficial basal cell carcinomas, and squamous cell carcinomas limited to the most superficial layer of the skin (in situ) may be candidates for removal with PreciseFX laser therapy.
The PreciseFX laser passes electricity through a gas-filled chamber to produce powerful light energy. This energy is then directed to the superficial and deep layers of the skin to the target area. PreciseFX is an ablative laser, meaning that the light energy completely removes the outermost layer of skin. In this case, these ablative properties are used to eliminate your superficial skin cancer or precancer cells in their entirety. Additionally, the light energy from PreciseFX selectively heats the deep layer of skin to stimulate the production of collagen.
This collagen is then used to replace the lost superficial layer with healthy, scar-free skin. The aesthetic outcomes from PreciseFX are enhanced by the precision of the laser, as the light energy does not impact the surrounding healthy skin. Consequently, this laser allows for the treatment of the smallest area possible and also provides a healthy cushion around the treated area to facilitate the recovery process.
Traditionally, the gold standard for treatment of superficial skin cancers has been electrodesiccation and curettage (ED&C). Unlike PreciseFX, an ED&C procedure is not depth selective and tends to cause more collateral damage to the healthy surrounding tissue. This results in delayed wound healing and potentially a higher risk for an unsightly scar.
The key benefit of the PreciseFX device is the ability to determine the exact depth of penetration. Using the precision of laser energy, PreciseFX is able to eradicate these superficial skin cancers with minimal scarring.
The scar from the PreciseFX laser is not comparable to the scar after traditional surgery. The most noticeable change in your skin is hypopigmentation (loss of pigment) in the area of treatment. Additionally, the recovery period from surgery is more prolonged and associated with a greater risk of infection than PreciseFX therapy. Consequently, surgical interventions may lead to a more pronounced disruption of your everyday life. PreciseFX allows for targeted therapy that maximizes your aesthetic outcome with minimal risk or downtime allowing you to get back to your routine much faster.
Non-surgical options such as topical medications or cryotherapy may also be used to treat actinic keratosis, superficial basal cell carcinomas, and squamous cell carcinomas in situ. These therapies, however, require multiple sessions and may have unintended side effects. PreciseFX laser therapy is a one-time treatment with focused efficacy that yields optimal medical and cosmetic results.
Dr. Khorasani and his highly-specialized team look forward to working with you to transform your medical or aesthetic goals into reality. To expedite a request for a consultation, message us securely, or contact Dr. Khorasani’s Manhattan office by phone at 347-574-8500. For more information about how to get in touch:CONTACT US